FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3091897821> ?p ?o ?g. }

• W3091897821 endingPage "300.e20" @default.
• W3091897821 startingPage "300.e15" @default.
• W3091897821 abstract "The standard intravesical treatment for high risk non muscle invasive bladder cancer (HRNMIBC) is Bacillus Calmette-Guérin (BCG), with failure often resulting in cystectomy. Radiofrequency-Induced Thermo-chemotherapeutic Effect Mitomycin (RITE-MMC) can be an alternative in BCG failure. There has been concern that RITE-MMC may delay an inevitable cystectomy, make it more technically challenging and worsen prognosis. The aim of this study was to assess operative challenges and oncological outcome in patients undergoing cystectomy for HRNMIBC who received RITE-MMC, and contrast them with those that did not.A retrospective study of a prospective cystectomy database was conducted. Patients treated from April 2011 to June 2017 were looked at. Inclusion criteria were HRNMIBC with BCG failure undergoing cystectomy. Patient demographics and tumour characteristics were analysed. Intraoperative blood loss and length of stay were used as surrogate markers for intra-operative difficulty. Kaplan-Meier curves were constructed to analyse all-cause mortality, cancer specific mortality and time to recurrence between the RITE-MMC treatment group and those that did not receive RITE-MMC. A multivariate analysis was conducted to assess factors that may influence readmission.Thirty-six patients who received RITE-MMC underwent cystectomy, compared to 102 that did not. Median ages were comparable at 72 and 69 years, respectively. Patients were followed up for a median of 24 months across the 2 groups. The commonest histological stage in both groups was CIS. There were no significant differences in intraoperative blood loss, length of stay and 90-day readmission between the 2 groups. There were proportionally fewer recurrences in the RITE-MMC group (16% vs. 19%) and median time to recurrence was longer in the RITE-MMC group (37 months vs. 24 months). Multivariate analysis did not reveal a significant correlation between pre-op RITE-MMC and post-operative readmission (P = 0.606). Survival curves show no significant difference in time to recurrence across both groups (P = 0.513), and no overall (P = 0.069) or cancer specific mortality (P = 0.129) dis-advantage was noted in the RITE-MMC group.We have found that RITE-MMC treatment does not result in a technically more challenging cystectomy and does not compromise oncological outcome compared to those patients undergoing cystectomy immediately post-BCG failure. We feel RITE-MMC remains a useful tool in a carefully selected group of patients who may not be willing to accept the morbidity of a cystectomy at the time, without significantly compromising their long-term outcome." @default.
• W3091897821 created "2020-10-15" @default.
• W3091897821 creator A5006332270 @default.
• W3091897821 creator A5009504486 @default.
• W3091897821 creator A5028415341 @default.
• W3091897821 creator A5036833504 @default.
• W3091897821 creator A5038001647 @default.
• W3091897821 creator A5041080524 @default.
• W3091897821 creator A5047481252 @default.
• W3091897821 creator A5055922744 @default.
• W3091897821 creator A5077112149 @default.
• W3091897821 date "2021-05-01" @default.
• W3091897821 modified "2023-09-30" @default.
• W3091897821 title "Cystectomy outcomes in patients who have failed Radiofrequency-induced Thermo-chemotherapeutic Effect Mitomycin-C (RITE-MMC) treatment for high-risk non-muscle invasive bladder cancer (HRNMIBC)–Does it complicate surgery and adversely impact oncological outcome?" @default.
• W3091897821 cites W1509250581 @default.
• W3091897821 cites W1514620388 @default.
• W3091897821 cites W1572827793 @default.
• W3091897821 cites W2002045993 @default.
• W3091897821 cites W2044903247 @default.
• W3091897821 cites W2122267678 @default.
• W3091897821 cites W2277438627 @default.
• W3091897821 cites W2599735007 @default.
• W3091897821 cites W2891837297 @default.
• W3091897821 cites W2893171711 @default.
• W3091897821 doi "https://doi.org/10.1016/j.urolonc.2020.09.016" @default.
• W3091897821 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33032922" @default.
• W3091897821 hasPublicationYear "2021" @default.
• W3091897821 type Work @default.
• W3091897821 sameAs 3091897821 @default.
• W3091897821 citedByCount "3" @default.
• W3091897821 countsByYear W30918978212021 @default.
• W3091897821 countsByYear W30918978212023 @default.
• W3091897821 crossrefType "journal-article" @default.
• W3091897821 hasAuthorship W3091897821A5006332270 @default.
• W3091897821 hasAuthorship W3091897821A5009504486 @default.
• W3091897821 hasAuthorship W3091897821A5028415341 @default.
• W3091897821 hasAuthorship W3091897821A5036833504 @default.
• W3091897821 hasAuthorship W3091897821A5038001647 @default.
• W3091897821 hasAuthorship W3091897821A5041080524 @default.
• W3091897821 hasAuthorship W3091897821A5047481252 @default.
• W3091897821 hasAuthorship W3091897821A5055922744 @default.
• W3091897821 hasAuthorship W3091897821A5077112149 @default.
• W3091897821 hasConcept C121608353 @default.
• W3091897821 hasConcept C126322002 @default.
• W3091897821 hasConcept C126894567 @default.
• W3091897821 hasConcept C141071460 @default.
• W3091897821 hasConcept C167135981 @default.
• W3091897821 hasConcept C2775910329 @default.
• W3091897821 hasConcept C2779338040 @default.
• W3091897821 hasConcept C2780352672 @default.
• W3091897821 hasConcept C71924100 @default.
• W3091897821 hasConceptScore W3091897821C121608353 @default.
• W3091897821 hasConceptScore W3091897821C126322002 @default.
• W3091897821 hasConceptScore W3091897821C126894567 @default.
• W3091897821 hasConceptScore W3091897821C141071460 @default.
• W3091897821 hasConceptScore W3091897821C167135981 @default.
• W3091897821 hasConceptScore W3091897821C2775910329 @default.
• W3091897821 hasConceptScore W3091897821C2779338040 @default.
• W3091897821 hasConceptScore W3091897821C2780352672 @default.
• W3091897821 hasConceptScore W3091897821C71924100 @default.
• W3091897821 hasIssue "5" @default.
• W3091897821 hasLocation W30918978211 @default.
• W3091897821 hasLocation W30918978212 @default.
• W3091897821 hasOpenAccess W3091897821 @default.
• W3091897821 hasPrimaryLocation W30918978211 @default.
• W3091897821 hasRelatedWork W1484554393 @default.
• W3091897821 hasRelatedWork W2120921122 @default.
• W3091897821 hasRelatedWork W2328067422 @default.
• W3091897821 hasRelatedWork W2331403566 @default.
• W3091897821 hasRelatedWork W2357375221 @default.
• W3091897821 hasRelatedWork W2377565710 @default.
• W3091897821 hasRelatedWork W2413337224 @default.
• W3091897821 hasRelatedWork W3111145153 @default.
• W3091897821 hasRelatedWork W4321792277 @default.
• W3091897821 hasRelatedWork W2118673085 @default.
• W3091897821 hasVolume "39" @default.
• W3091897821 isParatext "false" @default.
• W3091897821 isRetracted "false" @default.
• W3091897821 magId "3091897821" @default.
• W3091897821 workType "article" @default.